Clinical Trial

Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2024 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators propose a multicenter randomized trial to test the renal safety of 6% hydroxyethyl starch (HES) 130/0.4 combined with sodium acetate Ringer's crystalloid solution in moderate-to-high cardiovascular risk patients having major abdominal surgery. The reference group will only be given sodium acetate Ringer's crystalloid.
Trial Details
NCT Number NCT06663254
Lead Sponsor Xiangya Hospital of Central South University
Conditions Perioperative Volume Replacement, Hydroxyethyl Starch
Enrollment 410 participants
Start Date 2024-11-30
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-29